About Us
MyndTec is committed to the development and commercialization of pioneering neurotechnology products that enhance function, foster independence, and improve the quality of life for individuals affected by neurological disorders, chronic pain, and central nervous system injuries, including conditions resulting from stroke and spinal cord injury (SCI). Through advanced neuroimaging, neuromodulation, and regenerative therapies, the Company addresses both invasive and non-invasive therapeutic needs, specifically targeting large and expanding global patient populations.
What We Do?

AI-Enhanced Treatments
Using AI to optimize treatments for chronic pain and movement disorders

Better Patient Outcomes
Improved treatment success rates lead to enhanced quality of life

Cost
Savings
Efficient treatments improve patient outcomes and reduce healthcare expenditures
MyndTec brings over a decade of experience treating neurological patients, generating invaluable patient data and clinical insights. We have a proven track record of navigating and complying with FDA and Health Canada regulations and successfully commercializing medical technology. This strong foundation has uniquely positioned us to recognize and capitalize on the opportunity for AI to dramatically improve outcomes and reduce costs in neurological care.
The Company is dedicated to integrating machine learning and AI-enabled technologies to deliver data-driven, predictive insights that significantly improve patient outcomes. By embedding these advanced technologies, the Company aims to optimize resource use at the individual, corporate, and healthcare system levels, ultimately enhancing patient care, streamlining decision-making, and maximizing the efficiency of healthcare delivery.
Mission
MyndTec’s mission is to revolutionize the treatment of neurological disorders by advancing from neuromodulation to regenerative therapies. Through cutting-edge research, brain imaging, and personalized treatment approaches, we aim to restore patient independence, improve neurological function and deliver lasting, transformative health outcomes.
Vision
Our vision is to lead the future of neurological care by enhancing patient outcomes through innovative, precision-based treatments and building strategic partnerships that bring these groundbreaking, life-changing therapies to both patients and healthcare providers.